PlainRecalls
FDA Drug Moderate Class II Ongoing

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30

Reported: March 27, 2019 Initiated: March 7, 2019 #D-1052-2019

Product Description

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30

Reason for Recall

CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products

Details

Units Affected
30,530 bottles
Distribution
Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.
Location
Saddle Brook, NJ

Frequently Asked Questions

What product was recalled?
Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30. Recalled by Rising Pharmaceuticals, Inc.. Units affected: 30,530 bottles.
Why was this product recalled?
CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
Which agency issued this recall?
This recall was issued by the FDA Drug on March 27, 2019. Severity: Moderate. Recall number: D-1052-2019.